Global Digital Diabetes Management Market Growth Drivers 2024, Forecast To 2033
10 Jan, 2024
The digital diabetes management market has witnessed exponential growth, increasing from $13.27 billion in 2023 to $16.23 billion in 2024, reflecting a CAGR of 22.3%. Key drivers include the rising prevalence of diabetes, technological advancements, personalized healthcare, regulatory support, and the adoption of telehealth and remote monitoring. The market is expected to continue this trajectory, reaching $37.4 billion in 2028, driven by the persistent diabetes epidemic, AI and machine learning, data integration, and remote care models. Notable trends include continuous glucose monitoring (CGM), insulin delivery systems, mobile apps and wearables, and enhanced patient engagement and education.
Global Digital Diabetes Management Market Key Driver
The increasing prevalence of diabetes is anticipated to drive demand for digital diabetes management devices and related services. Diabetes, a leading cause of death, affected 537 million individuals in 2021, with projections reaching 783 million by 2045. The demand for digital solutions to manage diabetes is on the rise, indicating a growing market for digital diabetes management devices and services.
Get A Free Sample Of The Global Digital Diabetes Management Market ReportGlobal Digital Diabetes Management Market Segments
The digital diabetes management market covered in this report is segmented –
1) By Product & Service: Devices, Application, Data Management Software & Platforms, Services
2) By Device Type: Handheld Devices, Wearable Devices
3) By End User: Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users
By Geography: The regions covered in the digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the digital diabetes management market in 2023. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Digital Diabetes Management Industry Players
Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.
Get The Full Global Digital Diabetes Management Market Report
Digital Diabetes Management Market Overview
Digital diabetes management refers to using electronic medical solutions to monitor, analyze, and manage diabetics remotely. People with diabetes or those who are at risk of developing it can improve their health outcomes by successfully managing their condition on their own with the help of digital diabetes management.
Digital Diabetes Management Global Market Report 2023 provides data on the global digital diabetes management market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The digital diabetes management market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.